PET radiotracers for whole-body in vivo molecular imaging of prostatic neuroendocrine malignancies
D Cohen, S Hazut Krauthammer, I Fahoum… - European …, 2023 - Springer
Prostatic neuroendocrine malignancies represent a spectrum of diseases. Treatment-
induced neuroendocrine differentiation (tiNED) in hormonally treated adenocarcinoma has …
induced neuroendocrine differentiation (tiNED) in hormonally treated adenocarcinoma has …
[HTML][HTML] Deep UV microscopy identifies prostatic basal cells: an important biomarker for prostate cancer diagnostics
O OsunkoyaAdeboye, E RoblesFrancisco - BME frontiers, 2022 - spj.science.org
Abstract Objective and Impact Statement. Identifying benign mimics of prostatic
adenocarcinoma remains a significant diagnostic challenge. In this work, we developed an …
adenocarcinoma remains a significant diagnostic challenge. In this work, we developed an …
[HTML][HTML] Investigation of the Relationship Between Prostate-Specific Antigen Levels and Prostate Cancer in Patients Attending a Urology Clinic from 2014 to 2023
HM Rad, A Hosseinkhani, E Hosseinkhani… - Nephro-Urology Monthly - brieflands.com
Background: Prostate cancer is the second most common neoplasm and the fifth most
aggressive cancer among men worldwide, with approximately 1.4 million new cases …
aggressive cancer among men worldwide, with approximately 1.4 million new cases …
PET radiotracers for whole-body in-vivo molecular imaging of prostatic neuroendocrine malignancies: A case series and review of literature
D Cohen, SH Krauthammer, I Fahoum, M Kesler… - 2022 - researchsquare.com
Background Neuroendocrine malignancies of the prostate represent a spectrum of diseases.
Treatment-induced neuroendocrine differentiation (tiNED) in hormonally treated …
Treatment-induced neuroendocrine differentiation (tiNED) in hormonally treated …